Want to see SHPH full AI Analyst Report?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ropidoxuridine | Glioblastoma, Idh-Wildtype | Phase II | Recruiting | Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter | Mar 24, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ropidoxuridine | Phase II | Glioblastoma, Idh-Wildtype | Recruiting | Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter | Mar 24, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Shuttle Pharmaceuticals Holdings, Inc. (SHPH) have in its pipeline
Shuttle Pharmaceuticals Holdings, Inc. SHPH is currently developing the following drugs: Ropidoxuridine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.